FDA Clearance Tracker · K233710
Symphion Operative Hysteroscopy System
Last checked: Nov 20, 2026Latest source record: Jan 17, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 17, 2024
Substantially Equivalent
Time to decision
58 days
Received Nov 20, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233710
- Device name
- Symphion Operative Hysteroscopy System
- Applicant
- Minerva Surgical, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Nov 20, 2023
- Decided
- Jan 17, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 884.1710
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PGT. The earliest in FDA's data is DEN130040, decided Mar 28, 2014.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233710
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Minerva Surgical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.